Christopher Enny
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 2%
- Erythropoietin and Anemia Treatment
- Multiple Myeloma Research and Treatments
Papers in
-
- Lymphoma Diagnosis and Treatment 10
-
- Multiple Myeloma Research and Treatments 4
- Erythropoietin and Anemia Treatment 3
- Co-authors
- Howard L. Corwin (4 shared papers)Andrew Gettinger (3 shared papers)Michael J. Corwin (3 shared papers)Ronald G. Pearl (2 shared papers)Theodore Colton (2 shared papers)Robert M. Rodriguez (2 shared papers)Kelly Dean Gubler (2 shared papers)Helgi van de Velde (10 shared papers)
- Journals
- Blood (6 papers)Critical Care Medicine (3 papers)The Lancet Oncology (2 papers)Leukemia (1 paper)QJM (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Christopher Enny
23 papers receiving 2.5k citations
Christopher Enny's Hit Papers
Peers
Comparison fields: 5 of 122
- Genetics 523
- Hematology 533
- Biochemistry 278
- Pathology and Forensic Medicine 545
- Oncology 797
Countries citing papers authored by Christopher Enny
This map shows the geographic impact of Christopher Enny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Enny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Enny more than expected).
Fields of papers citing papers by Christopher Enny
This network shows the impact of papers produced by Christopher Enny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Enny. The network helps show where Christopher Enny may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Enny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial. Hit paper breakdown → | 2011 | 1133 |
| 2 | Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study Hit paper breakdown → | 2015 | 375 |
| 3 | 1999 | 270 | |
| 4 | 2011 | 142 | |
| 5 | 2015 | 113 | |
| 6 | 2011 | 97 | |
| 7 | 2009 | 78 | |
| 8 | 2012 | 69 | |
| 9 | 2006 | 66 | |
| 10 | 2006 | 63 | |
| 11 | 2008 | 63 | |
| 12 | 2014 | 61 | |
| 13 | 2011 | 39 | |
| 14 | 2015 | 24 | |
| 15 | 2001 | 21 | |
| 16 | 2012 | 18 | |
| 17 | 2017 | 17 | |
| 18 | 2010 | 12 | |
| 19 | 2009 | 6 | |
| 20 | 2022 | 5 |
About Christopher Enny
Christopher Enny is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Oncology and Biochemistry, having authored 23 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Erythropoietin and Anemia Treatment (3 papers), Blood transfusion and management (2 papers), Viral-associated cancers and disorders (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Genetics (523 citations), Hematology (533 citations), Biochemistry (278 citations), Pathology and Forensic Medicine (545 citations) and Oncology (797 citations). Christopher Enny has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Howard L. Corwin, Andrew Gettinger, Michael J. Corwin, Ronald G. Pearl, Theodore Colton, Robert M. Rodriguez, Kelly Dean Gubler, Helgi van de Velde, Wayne K. Langholff and Dixie‐Lee Esseltine. Their work appears in journals such as Blood, Critical Care Medicine, The Lancet Oncology, Leukemia and QJM.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.